| Literature DB >> 33142505 |
Shan Gao1, Runhua Li1, Nuo Heng1, Yu Chen2, Liang Wang2, Zheng Li3, Yong Guo1, Xihui Sheng1, Xiangguo Wang1, Kai Xing1, Hemin Ni1, Xiaolong Qi4.
Abstract
The present study evaluated the effects of natural astaxanthin (ASTA) from Haematococcus pluvialis on the antioxidant capacity, lipid metabolism, and ASTA accumulation in the egg yolk of laying hens. Hy-Line Brown layers (n = 288, 50 wk old) were randomly assigned to 1 of 4 dietary treatment groups. Each group had 6 replicates of 12 hens each. All birds were given a corn-soybean meal-based diet containing 0, 25, 50, or 100 mg/kg ASTA for 6 wk. The results showed that the total antioxidant capacity, superoxide dismutase level, and glutathione peroxidase level in the plasma, livers, and egg yolks were significantly increased in the ASTA groups compared with those of the control group (P < 0.05), whereas the content of malondialdehyde linearly decreased (P < 0.05). The plasma levels of high-density and very-low-density lipoprotein cholesterol in the ASTA groups were significantly higher than those in the control group (P < 0.05). In addition, ASTA supplementation decreased low-density lipoprotein cholesterol and triglyceride plasma levels (P < 0.05). However, there were no significant differences in the other lipid metabolism parameters among the ASTA-supplemented groups relative to the control group except for an increase in high-density lipoprotein cholesterol in the liver. Compared with the control, dietary ASTA supplementation significantly increased the enrichment of ASTA in egg yolks at the end of week 2, 4, and 6 (P < 0.05). The mRNA expression of scavenger receptor class B type 1 (SCARB1) and very-low-density lipoprotein receptor (VLDLR) in the ASTA groups was markedly higher (P < 0.05) than that in the control group in the liver and ovaries, respectively. In conclusion, these results suggest that dietary ASTA enhances the antioxidant capacity and regulates lipid metabolism in laying hens. ASTA enrichment in egg yolks may be closely related to the upregulation of SCARB1 and VLDLR gene expression.Entities:
Keywords: SCARB1; VLDLR; antioxidant enzyme; laying hen; natural astaxanthin
Mesh:
Substances:
Year: 2020 PMID: 33142505 PMCID: PMC7647864 DOI: 10.1016/j.psj.2020.08.029
Source DB: PubMed Journal: Poult Sci ISSN: 0032-5791 Impact factor: 3.352
Composition and nutrient content of basal diets of laying hens (air dried basis, %).1
| Ingredient | Content, % | Nutrient level | |
|---|---|---|---|
| Corn | 62.66 | Metabolizable energy [MJ/kg] | 11.68 |
| Soybean meal | 25.66 | Crude protein [%] | 16.50 |
| Limestone | 8.33 | Calcium [%] | 3.50 |
| Soybean oil | 0.60 | Methionine [%] | 0.32 |
| (Wheat) bran | 0.06 | Lysine [%] | 0.77 |
| Premix1 | 0.54 | Total phosphorus [%] | 0.60 |
| Salt | 0.49 | Tryptophan [%] | 0.17 |
| Choline | 0.16 | ||
| Dicalcium phosphate | 1.50 | ||
| Total | 100.00 |
The premix provided the following per kilogram of the diet: vitamin A 9,000 IU, vitamin D 2,000 IU, vitamin E 10 IU, vitamin K 0.5 mg, vitamin B2 0.006 mg, vitamin B6 52.5 mg, vitamin B12 0.4 mg, biotin 4.5 mg, folic acid 4.0 mg, D-pantothenic acid 4 mg, nicotinic acid 30 mg, Cu (as copper sulfate) 8 mg, Fe (as ferrous sulfate) 60 mg, Mn (as manganese sulfate) 65 mg, Zn (as zinc sulfate) 90 g, I (as potassium iodide) 0.5 mg, and Se (as sodium selenite) 0.3 mg.
Calculated values.
Measured values.
Primer sequences used for quantitative real-time PCR.
| Genes | Primer sequence (5′-3′) | Product size | Tm (°C) | Accession number |
|---|---|---|---|---|
| F- CGCATAAAACAAGACGAGA | 91 bp | 62 | NM_205518.1 | |
| F- TGAGGATGGGTCTGACGAGAG | 275 bp | 62 | NM_205229.1 | |
| F- TCACTTCTACAATGCTGACCCAA | 241 bp | 62 | XM_015275627.2 |
Effect of dietary astaxanthin (ASTA) supplementation on antioxidant enzyme activities and lipid peroxidation levels in the plasma of laying hens.
| Items | ASTA levels/(mg/kg) | SEM | |||||
|---|---|---|---|---|---|---|---|
| 0 | 25 | 50 | 100 | Linear | Quadratic | ||
| GSH-Px (U/mL) | 417.13b | 438.16a | 440.46a | 438.05a | 2.43 | <0.01 | <0.01 |
| MDA (nmol/mL) | 7.87a | 6.31b | 2.85c | 1.92d | 0.52 | <0.01 | 0.30 |
| SOD (U/mL) | 311.39b | 334.55a,b | 348.33a | 346.47a | 5.37 | 0.011 | 0.20 |
| T-AOC (U/mL) | 0.34b | 0.43a | 0.46a | 0.45a | 0.02 | <0.01 | 0.02 |
a,bMeans within a row with no common superscripts differ significantly (P < 0.05).
Abbreviations: GSH-Px, glutathione peroxidase; MDA, malondialdehyde; SOD, superoxide dismutase; T-AOC, total antioxidant capacity.
Effect of dietary astaxanthin (ASTA) supplementation on antioxidant enzyme activities and lipid peroxidation levels in the liver of laying hens.
| Items | ASTA levels/(mg/kg) | SEM | |||||
|---|---|---|---|---|---|---|---|
| 0 | 25 | 50 | 100 | Linear | Quadratic | ||
| GSH-Px (U/mg prot) | 24.36d | 29.11c | 37.97a | 31.68b | 1.07 | <0.01 | <0.01 |
| MDA (nmol/mg prot) | 0.80a | 0.63a,b | 0.58b | 0.57b | 0.023 | <0.01 | 0.12 |
| SOD (U/mg prot) | 268.97c | 315.02b | 369.55a | 318.76b | 7.77 | <0.01 | <0.01 |
| T-AOC (U/mg prot) | 0.034c | 0.038b | 0.048a | 0.037b,c | 0.0012 | <0.01 | <0.01 |
a-cMeans within a row with no common superscripts differ significantly (P < 0.05).
Abbreviations: GSH-Px, glutathione peroxidase; MDA, malondialdehyde; SOD, superoxide dismutase; T-AOC, total antioxidant capacity.
Effect of dietary astaxanthin (ASTA) supplementation on antioxidant enzyme activities and lipid peroxidation levels in the egg yolk of laying hens.
| Items | Time/week | ASTA levels/(mg/kg) | SEM | |||||
|---|---|---|---|---|---|---|---|---|
| 0 | 25 | 50 | 100 | Linear | Quadratic | |||
| GSH-Px (U/ml) | 2 | 1,174.36b | 1,856.39a | 1,535.90a,b | 1,707.70a,b | 103.12 | 0.12 | 0.15 |
| 4 | 1,271.06c | 2,274.73b | 2,915.75a | 2,714.29a,b | 156.22 | <0.01 | <0.01 | |
| 6 | 1,245.61c | 4,695.91a | 4,725.15a | 4,049.71b | 301.79 | <0.01 | <0.01 | |
| MDA (nmol/ml) | 2 | 688.38a | 558.58b | 562.62b | 535.86b | 16.32 | <0.01 | <0.01 |
| 4 | 630.00a | 553.34b | 525.56b | 523.33b | 18.21 | <0.01 | <0.01 | |
| 6 | 663.89a | 467.59b | 438.88b,c | 394.44c | 32.34 | <0.01 | <0.01 | |
| SOD (U/ml) | 2 | 534.72b | 671.72a | 550.71b | 546.77b | 14.78 | 0.034 | <0.01 |
| 4 | 555.31b | 625.78a | 645.99a | 615.59a | 9.14 | <0.01 | <0.01 | |
| 6 | 537.97b | 657.85a | 675.16a | 656.42a | 13.63 | <0.01 | <0.01 | |
a-cMeans within a row with no common superscripts differ significantly (P < 0.05).
Abbreviations: GSH-Px, glutathione peroxidase; MDA, malondialdehyde; SOD, superoxide dismutase.
Effect of dietary astaxanthin (ASTA) addition on lipid metabolism in the plasma.
| Items | ASTA levels/(mg/kg) | SEM | |||||
|---|---|---|---|---|---|---|---|
| 0 | 25 | 50 | 100 | Linear | Quadratic | ||
| HDL-C (mmol/L) | 0.43b | 0.48a,b | 0.53a,b | 0.68a | 0.04 | 0.02 | 0.42 |
| LDL-C (mmol/L) | 0.40a | 0.38a | 0.31b | 0.20c | 0.02 | <0.01 | <0.01 |
| TG (mmol/L) | 4.59a | 4.36a | 4.59a | 3.57b | 0.12 | <0.01 | 0.03 |
| TC (mmol/L) | 3.29 | 3.22 | 3.16 | 2.79 | 0.10 | 0.12 | 0.47 |
| VLDL-C (mmol/L) | 1.78b | 1.88b | 2.26a | 2.33a | 0.08 | <0.01 | 0.88 |
a-cMeans within a row with no common superscripts differ significantly (P < 0.05).
Abbreviations: HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; TC, total cholesterol; TG, triglyceride; VLDL-C, very-low-density lipoprotein cholesterol.
Effect of dietary astaxanthin (ASTA) addition on lipid metabolism in the liver.
| Items | ASTA levels/(mg/kg) | SEM | |||||
|---|---|---|---|---|---|---|---|
| 0 | 25 | 50 | 100 | Linear | Quadratic | ||
| HDL-C (mmol/gprot) | 0.024c | 0.032b | 0.039a | 0.033b | 0.0014 | <0.01 | <0.01 |
| LDL-C (mmol/gprot) | 0.0098 | 0.0089 | 0.0087 | 0.0089 | 0.0005 | 0.58 | 0.61 |
| TG (mmol/gprot) | 0.083 | 0.082 | 0.083 | 0.082 | 0.0013 | 0.91 | 0.98 |
| TC (mmol/gprot) | 0.044 | 0.046 | 0.048 | 0.045 | 0.0013 | 0.61 | 0.43 |
| VLDL-C (mmol/gprot) | 0.030 | 0.030 | 0.040 | 0.033 | 0.0036 | 0.57 | 0.66 |
a-cMeans within a row with no common superscripts differ significantly (P < 0.05).
Abbreviations: HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; TC, total cholesterol; TG, triglyceride; VLDL-C, very-low-density lipoprotein cholesterol.
Effect of dietary astaxanthin (ASTA) on the egg yolk ASTA content.
| Items | Time/week | ASTA levels/(mg/kg) | SEM | |||||
|---|---|---|---|---|---|---|---|---|
| 0 | 25 | 50 | 100 | Linear | Quadratic | |||
| ASTA content (mg/kg) | 2 | - | 3.69c | 11.13b | 34.95a | 2.91 | <0.01 | <0.01 |
| 4 | - | 8.07c | 17.56b | 37.47a | 3.06 | <0.01 | <0.01 | |
| 6 | - | 12.87c | 21.06b | 44.20a | 3.46 | <0.01 | <0.01 | |
a-cMeans within a row with no common superscripts differ significantly (P < 0.05).
Figure 1The effects of dietary astaxanthin (ASTA) supplementation on the mRNA expression of SCARB1 (A) and VLDLR (B) relative to that of β-actin (ACTB). The values are expressed as means ± SEM of 6 birds per treatment. Means without a common letter differ (P < 0.05).